⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CLLS News
Cellectis S.A. American Depositary Shares
Monthly information on share capital and company voting rights
globenewswire.com
CLLS
ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
businesswire.com
PFE
AZN
UMBF
CLLS
REGN
Cellectis Announces 2026 Strategy and Catalysts
globenewswire.com
CLLS
セルトリオン、SteQeyma ™（ウステキヌマブバイオシミラー）オートインジェクターについてCHMPの承認勧告を獲得
businesswire.com
CLLS
Allogene Therapeutics Reports Favorable Result for Servier in Arbitration with Cellectis
globenewswire.com
ALLO
CLLS
Cellectis Announces Arbitral Decision in Dispute with Servier
globenewswire.com
CLLS
ASH 2025: Cellectis Presents Development Plan to Further Enhance High Response Rate Observed for Eti-cel in r/r NHL
globenewswire.com
CLLS
Moligo Technologies and Cellectis Demonstrate Potential of Enzymatic Single-Stranded DNA for Non-Viral Gene Editing in Nature Communications
prnewswire.com
CLLS
Cellectis Publishes Nature Communications Article on a Non-Viral Gene Editing Process Enabling Efficient Gene Insertion in Hematopoietic Stem Cells
globenewswire.com
CLLS